Psychiatric News Alert
Compared with intranasal esketamine, intramuscular ketamine demonstrated comparable effectiveness and safety for patients with treatment-resistant depression (TRD) at just a fraction of the cost, according to a study published in Psychiatric Research and Clinical Practice.